{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:39:18Z","timestamp":1790667558856,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.antiviral.2020.104997","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T01:26:55Z","timestamp":1607995615000},"page":"104997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-6517","authenticated-orcid":false,"given":"Ila","family":"Nimgaonkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2714-9572","authenticated-orcid":false,"given":"Nicholas F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-2235","authenticated-orcid":false,"given":"Isabelle","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8214-9583","authenticated-orcid":false,"given":"Mohammad","family":"Shahrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-4523","authenticated-orcid":false,"given":"Robert A.","family":"LeDesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-0677","authenticated-orcid":false,"given":"Andr\u00e9","family":"Mateus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Caballero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1216-5692","authenticated-orcid":false,"given":"Andrew R.","family":"Berneshawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Douam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1706-9701","authenticated-orcid":false,"given":"Jenna M.","family":"Gaska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail M.","family":"Savitski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hahn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9322-7252","authenticated-orcid":false,"given":"Alexander","family":"Ploss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104997_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nchembio.2185","article-title":"Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat","volume":"12","author":"Becher","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2020.104997_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJM200301093480218","article-title":"Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus","volume":"348","author":"Benhamou","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104997_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2014.08.040","article-title":"A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients","volume":"147","author":"Debing","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104997_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2016.05.002","article-title":"Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity","volume":"65","author":"Debing","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104997_bib5","series-title":"Identification of the Intragenomic Promoter Controlling Hepatitis E Virus Subgenomic RNA Transcription","author":"Ding","year":"2018"},{"key":"10.1016\/j.antiviral.2020.104997_bib6","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-07-5256","article-title":"NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis","volume":"68","author":"Eccles","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.antiviral.2020.104997_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbamcr.2011.11.007","article-title":"Broad action of Hsp90 as a host chaperone required for viral replication","volume":"1823","author":"Geller","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2020.104997_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.22014","article-title":"Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b","volume":"16","author":"Haagsma","year":"2010","journal-title":"Liver Transplant."},{"key":"10.1016\/j.antiviral.2020.104997_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","article-title":"Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation","volume":"89","author":"Kamar","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2020.104997_bib10","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection","volume":"370","author":"Kamar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104997_bib11","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.3748\/wjg.v22.i31.7030","article-title":"Hepatitis E: discovery, global impact, control and cure","volume":"22","author":"Khuroo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2020.104997_bib12","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1073\/pnas.89.17.8259","article-title":"Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses","volume":"89","author":"Koonin","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104997_bib13","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/j.ijid.2012.11.026","article-title":"Hepatitis E virus: the current scenario","volume":"17","author":"Kumar","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104997_bib14","series-title":"Hepatitis E Virus Replication","author":"LeDesma","year":"2019"},{"key":"10.1016\/j.antiviral.2020.104997_bib15","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/AAC.01058-08","article-title":"In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor","volume":"53","author":"Lin","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104997_bib16","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.exphem.2008.05.001","article-title":"The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors","volume":"36","author":"Lin","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.antiviral.2020.104997_bib17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/AAC.50.3.1013-1020.2006","article-title":"SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells","volume":"50","author":"Malcolm","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104997_bib18","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/hep.22550","article-title":"Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells","volume":"48","author":"Marukian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104997_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12953-017-0122-4","article-title":"Thermal proteome profiling: unbiased assessment of protein state through heat-induced stability changes","volume":"15","author":"Mateus","year":"2016","journal-title":"Proteome Sci."},{"key":"10.1016\/j.antiviral.2020.104997_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005695","article-title":"Expanding host range and cross-species infection of hepatitis E virus","volume":"12","author":"Meng","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104997_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/138161213804143725","article-title":"The therapeutic target Hsp90 and cancer hallmarks","volume":"19","author":"Miyata","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.antiviral.2020.104997_bib22","first-page":"96","article-title":"Hepatitis E virus: advances and challenges. Nature reviews","volume":"15","author":"Nimgaonkar","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104997_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2015.12.007","article-title":"Hepatitis E virus ORF1 encoded non structural protein-host protein interaction network","volume":"213","author":"Ojha","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2020.104997_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1929","article-title":"Hepatitis E and pregnancy: current state","volume":"27","author":"P\u00e9rez-Gracia","year":"2017","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104997_bib25","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104997_bib26","doi-asserted-by":"crossref","first-page":"1255784","DOI":"10.1126\/science.1255784","article-title":"Tracking cancer drugs in living cells by thermal profiling of the proteome","volume":"346","author":"Savitski","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104997_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2020.104997_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002800050817","article-title":"The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin","volume":"42","author":"Schulte","year":"1998","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104997_bib29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1158\/1535-7163.MCT-07-0149","article-title":"Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole\/isoxazole amide analogues","volume":"6","author":"Sharp","year":"2007","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.antiviral.2020.104997_bib30","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1073\/pnas.1018878108","article-title":"Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant","volume":"108","author":"Shukla","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104997_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104997_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1756283X13515825","article-title":"Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential","volume":"7","author":"Stedman","year":"2014","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.antiviral.2020.104997_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0042-6822(91)90760-9","article-title":"Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome","volume":"185","author":"Tam","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104997_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coviro.2018.10.001","article-title":"Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse","volume":"32","author":"Todt","year":"2018","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.antiviral.2020.104997_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2018.07.010","article-title":"The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo","volume":"157","author":"Todt","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104997_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1073\/pnas.89.2.559","article-title":"Characterization of a prototype strain of hepatitis E virus","volume":"89","author":"Tsarev","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104997_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jhep.2016.09.014","article-title":"Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection","volume":"66","author":"van der Valk","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104997_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz346","article-title":"Sofosbuvir add-on to ribavirin treatment for chronic hepatitis E virus infection in solid organ transplant recipients does not result in sustained virological response","volume":"6","author":"van Wezel","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.antiviral.2020.104997_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1099\/vir.0.027714-0","article-title":"Hepatitis E virus replication involves alternating negative- and positive-sense RNA synthesis","volume":"92","author":"Varma","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104997_bib40","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1099\/vir.0.019323-0","article-title":"Role of heat-shock protein 90 in hepatitis E virus capsid trafficking","volume":"91","author":"Zheng","year":"2010","journal-title":"J. Gen. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220304113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220304113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:33:06Z","timestamp":1759062786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220304113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"alternative-id":["S0166354220304113"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104997","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104997"}}